BeOne Medicines AG Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	5,343	3,810	2,459	1,416	1,176
Revenue Growth (YoY)	40.23%	54.96%	73.65%	20.37%	280.83%
Cost of Revenue	668.54	594.09	379.92	286.48	164.91
Gross Profit	4,674	3,216	2,079	1,129	1,011
Selling, General & Admin	2,081	1,831	1,508	1,279	990.12
Depreciation & Amortization Expenses	-	-	-	-	0.75
Research & Development	2,146	1,953	1,779	1,641	1,459
Total Operating Expenses	4,227	3,784	3,287	2,919	2,450
Operating Income	447.14	-568.2	-1,208	-1,790	-1,439
Interest Income	70.51	69.64	74.01	52.48	-15.76
Interest Expense	-58.23	-21.81	-	-	-
Other Non-Operating Income (Expense)	-42.55	-12.64	307.89	-223.85	15.9
Total Non-Operating Income (Expense)	-30.28	35.2	381.9	-171.37	0.15
Pretax Income	416.85	-533	-825.84	-1,961	-1,439
Provision for Income Taxes	129.92	111.79	55.87	42.78	-25.23
Net Income	286.93	-644.79	-881.71	-2,004	-1,413
Net Income to Common	286.93	-644.79	-881.71	-2,004	-1,413
Shares Outstanding (Basic)	109	105	104	103	93
Shares Outstanding (Diluted)	113	105	104	103	93
Shares Change (YoY)	7.75%	0.86%	1.22%	11.15%	11.16%
EPS (Basic)	2.60	-6.11	-8.45	-19.37	-15.73
EPS (Diluted)	2.47	-6.11	-8.45	-19.37	-15.73
Free Cash Flow	941.74	-633.29	-1,719	-1,822	-1,562
Free Cash Flow Per Share	8.30	-6.01	-16.47	-17.67	-16.83
Gross Margin	87.49%	84.41%	84.55%	79.77%	85.98%
Operating Margin	8.37%	-14.91%	-49.12%	-126.40%	-122.31%
Profit Margin	5.37%	-16.92%	-35.86%	-141.52%	-120.15%
FCF Margin	17.63%	-16.62%	-69.93%	-128.68%	-132.76%
EBITDA	588.82	-396.44	-1,120	-1,723	-1,392
EBITDA Margin	11.02%	-10.40%	-45.55%	-121.71%	-118.36%
EBIT	447.14	-568.2	-1,208	-1,790	-1,439
EBIT Margin	8.37%	-14.91%	-49.12%	-126.40%	-122.31%
Effective Tax Rate	31.17%	-20.97%	-6.77%	-2.18%	1.75%

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q